These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1373425)

  • 21. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM; Singhania SS; Basu A; Banerjee K
    Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
    Orlik O; Altaner C
    J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of polyethylene glycols as fusogens for producing lymphocyte-myeloma hybrids.
    Lane RD; Crissman RS; Lachman MF
    J Immunol Methods; 1984 Aug; 72(1):71-6. PubMed ID: 6747307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of hybridoma production by medium supplemented with murine ascitic fluid.
    Stewart SS; Fuller SA
    J Immunol Methods; 1989 Sep; 123(1):45-53. PubMed ID: 2794529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of stable human-mouse hybridomas secreting monoclonal antibodies against Rh D and c antigens.
    Rapaille A; François-Gérard C; Donnay D; Sondag-Thull D
    Vox Sang; 1993; 64(3):161-6. PubMed ID: 8484248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-mouse red blood cell monoclonal antibodies use functionally rearranged genes from the VH J558 family and are derived from the CD5- B-lymphocyte subpopulation.
    Scott BB; Sadigh S; Stow M; Mageed RA; Andrew EM; Maini RN
    Immunology; 1993 Aug; 79(4):568-73. PubMed ID: 7691732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased yield of antibody-producing murine spleen cell hybridomas from fusions cultured in medium supplemented with mouse serum.
    Persson MA; Lerner RA
    J Immunol Methods; 1990 Feb; 127(1):39-42. PubMed ID: 2319141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasciola hepatica:Sp2/0 (helminth:myeloma) hybridoma expressing parasite antigen.
    Hillyer GV
    Am J Trop Med Hyg; 1989 Dec; 41(6):674-9. PubMed ID: 2641645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Production of monoclonal antibodies against human cytomegalovirus].
    Mazeron MC; Berbar T; Guillemin MC; Colimon R; Roseto A; Perol Y
    C R Seances Acad Sci III; 1983; 297(6):305-8. PubMed ID: 6318932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on monoclonal antibody against recombinant human granulocyte colony-stimulating factor.
    Guo X; Wang A; Li X; Guo Z; Zhang Y
    Chin Med Sci J; 1991 Dec; 6(4):212-6. PubMed ID: 1725968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of hybridomas generated by spleen cells of IL-4- and IL-13-knockout mice.
    Shichkin VP; Spivak NY
    Hybridoma (Larchmt); 2005 Dec; 24(6):291-7. PubMed ID: 16332195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Generation and characteristics of hybridomas producing monoclonal antibodies to the surface antigen of hepatitis B virus].
    Kushch AA; Momot AM; Shumaĭ EP; Bukrinskaia AG; Anan'ev VA
    Vopr Virusol; 1987; 32(4):448-51. PubMed ID: 3318133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
    Başalp A; Yücel F
    Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid isolation of monoclonal hybridoma cultures by a 'fusion-cloning' method: the requirement for aminopterin.
    Butcher RN; Obi TU; McCullough KC
    Biologicals; 1991 Jul; 19(3):171-5. PubMed ID: 1954000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW; Jahn S; Grunow R
    Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
    Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
    Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.